Site Success

Category

Atrium Health Helps Pave Path Toward Clinical Research as a Care Option Targeting COVID-19 with Three New Clinical Trials Offering Outpatient Hope

Atrium Health, formerly the Carolinas HealthCare System, has been active on multiple fronts battling COVID-19. The nonprofit network of over 40 hospitals and over 900 care locations in North Carolina, South Carolina, and Georgia have also emerged as a leading player...

Karmanos Cancer Institute Launches Diversity & Inclusion Committee & Participates in the Detroit Renaissance

With the move to precision medicine, especially in oncology, the inclusion of diverse populations in research and development can be a matter of life and death. Thought of another way, with ethnic minorities and others considered underrepresented experiencing cancer...

Nitazoxanide Used Off Label in Laredo, TX, to Successfully Treat COVID-19: Now Clinical Trials!

A Laredo, Texas, area physician, Dr. Asuncion Ramos Soriano, was recently profiled in local media discussing a novel clinical trial in that part of deep southern Texas. After training back east at NYU and Johns Hopkins, Dr. Soriano has been caring for people along the...

Scripps’ Disney Lab Breakthrough RNA-Targeting Compounds Dismantle COVID-19’s ‘Clutch’ via Disabling Reproduction Engine

Research rockstar Matthew Disney, PhD, and team from Scripps Florida have created drug-like compounds that based on results thus far in human cell studies, actually bind and destroy the “frameshifting element” associated with SARS-CoV-2, the virus behind COVID-19,...

NHS Grampian via Aberdeen Royal Infirmary Seeks 450 Volunteers for NVX-CoV2373 COVID-19 Vaccine Phase 3 Trial in NE, Scotland

Back in August, the UK and American vaccine maker Novavax announced an agreement to proceed to a Phase 3 clinical trial testing that company’s COVID-19 experimental vaccine called NVX-CoV2373. This randomized, double-blind, placebo-controlled efficacy study targets...

Celerion Achieves Reaccreditation for Protection of Human participants in Clinical Research: The Only CRO?

Celerion, a contract research organization (CRO) known to be a leader in early-stage safety-based studies, has roots in the Midwest that go back 80 years. Recently, the company reported its successful reaccreditation by the Association for the Accreditation of Human...

NCI Injects $111m into NYC’s Montefiore & Einstein to Prevent & Treat HIV-Associated Cancers

Modern medicine, often a near miracle, creates more challenges to solve. For instance, the adoption worldwide of antiretroviral therapies to suppress the HIV virus has helped tens of millions of people with HIV live healthier, longer lives. However, with this...

Advent Health Ocala’s ICAM Protocol Takes on COVID-19: Clinician Drives Real World Evidence & Breakthrough

Physicians, nurses, and all healthcare workers have served heroically during this pandemic, not only in the U.S. but all over the world. Faced with a novel coronavirus and minimal treatment options, and in the case of remdesivir, severe shortages and high cost—Health...

Eli Lilly’s BLAZE-1 Selects Aventiv Research in Columbus as Ohioans Investigate Advanced Monoclonal Antibodies Targeting COVID-19

TrialSite recently profiled Columbus, Ohio-based Aventiv Research as the independent trial site organization was selected by Pfizer as a site to participate in the BNT162 COVID-19 vaccine trial program. Now, local media (WSYX/WTTE) reports that the Columbus-based site...

Columbia University Research Returned, Reactivated and Approaching 100% Capacity

Although a significant number of clinical trials conducted at Columbia University’s Irving Medical Center (CUIMC) were put on hold or delayed during the height of the pandemic in the spring, with the late summer Vagelos College of Physicians and Surgeons and other...